ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

GLYC GlycoMimetics Inc

1.8399
0.1199 (6.97%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
GlycoMimetics Inc GLYC 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.1199 6.97% 1.8399 13:00:05
개장가 저가 고가 종가 전일 종가
1.67 1.63 1.84 1.83 1.72
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202420:00BWGlycoMimetics to Report First Quarter 2024 Financial Results..
27/03/202420:00BWGlycoMimetics Reports Highlights and Financial Results for..
13/03/202420:00BWGlycoMimetics to Report Fourth Quarter and 2023 Full Year..
01/03/202423:16EDGAR2Form 8-K - Current report
26/02/202421:00BWGlycoMimetics to Participate in Upcoming Cowen 44th Annual..
12/02/202421:00BWGlycoMimetics Reports Inducement Grant Under NASDAQ Listing..
18/01/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/01/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/01/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/01/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/01/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202421:00BWGlycoMimetics Announces Positive Initial Safety and..
03/01/202421:00GLOBEApollomics Completes Enrollment in Phase 3 Bridging Study of..
03/01/202406:30EDGAR2Form 8-K - Current report
03/01/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202302:00BWGlycoMimetics Announces Independent Presentations on..
09/11/202321:00BWGlycoMimetics to Participate in Upcoming Jefferies London..
03/11/202321:35EDGAR2Form 8-K - Current report
03/11/202321:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202320:00BWGlycoMimetics Reports Highlights and Financial Results for..
23/10/202321:30PRNUSAnixa Biosciences Appoints Accomplished Medical Oncologist..
20/10/202320:00BWGlycoMimetics to Report Third Quarter 2023 Financial Results..
04/10/202305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202305:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202305:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/09/202305:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/09/202320:00BWGlycoMimetics Announces First Cohort Dosed in Human Phase 1a..
05/09/202320:00BWGlycoMimetics to Participate in Upcoming H.C. Wainwright..
17/08/202320:00BWGlycoMimetics Reports Inducement Grant Under Nasdaq Listing..
02/08/202321:35EDGAR2Form 8-K - Current report
02/08/202321:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/08/202320:00BWGlycoMimetics Reports Highlights and Financial Results for..
19/07/202320:00BWGlycoMimetics to Report Second Quarter 2023 Financial..
26/06/202321:00BWGlycoMimetics Announces Its Addition to the Russell..
15/06/202321:00BWGlycoMimetics Announces U.S. Food and Drug Administration..
31/05/202320:00BWGlycoMimetics to Participate in Upcoming Jefferies 2023..

최근 히스토리

Delayed Upgrade Clock